Altshuler Shaham LTD Veracyte, Inc. Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $26,780 - $46,032	-813 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $10,005 - $18,310	225 Added 38.27%	813 $44,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $19,104 - $36,385	588 New	588 $29,000
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $10,359 - $13,423	-434 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$22.1 - $28.56 $640 - $828	29 Added 7.16%	434 $12,000
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $4,860 - $10,432	405 New	405 $10,000
Q4 2018 Feb 11, 2019	SELL	$9.15 - $14.85 $5,599 - $9,088	-612 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$9.55 - $12.64 $5,844 - $7,735	612 New	612 $6,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.